awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33764062-083562E4-5CB5-4702-B1CF-693F52C14FC4
Q33764062-083562E4-5CB5-4702-B1CF-693F52C14FC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33764062-083562E4-5CB5-4702-B1CF-693F52C14FC4
Rituximab in indolent lymphomas.
P2860
Q33764062-083562E4-5CB5-4702-B1CF-693F52C14FC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33764062-083562E4-5CB5-4702-B1CF-693F52C14FC4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3ca0f089478231e76531e5091bff23ccc7952150
P2860
Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study